Dossier
New York-Presbyterian Hospital
Coverage of New York-Presbyterian Hospital in the Nexus archive.
- STAT+: A sweeping new AI to detect heart conditions is coming to OpenEvidence
EchoNext, an AI model developed by New York-Presbyterian Hospital researchers and commercialized by Pathway Labs, has received FDA clearance to detect seven forms of structural heart disease from EKGs. Pathway Labs will license the technology to OpenEvidence, a medical evidence search engine used by hundreds of thousands of clinicians.